Why should I get female infertility blood testing?

It quickly pinpoints common, fixable reasons for trouble conceiving. The panel shows if you’re ovulating (progesterone), whether ovarian reserve signaling is strained (FSH/estradiol), if the pattern fits PCOS (LH/FSH), whether high prolactin is blocking ovulation, and if thyroid imbalance is disturbing cycles (TSH). It turns symptoms into objective physiology so next steps are targeted.

Can I get a blood test at home?

Yes. With Superpower, our team can organize a licensed professional to draw your blood in your home and handle all logistics.

How often should I test?

Timing matters more than frequency. Baseline FSH, LH, and estradiol are typically checked on cycle days 2–3. Progesterone is best 7 days after ovulation (around day 21 in a 28‑day cycle) to confirm ovulation. Prolactin is often morning. TSH can be measured any day. Abnormal results are usually repeated to confirm, and panels are rechecked as your cycle pattern or care plan changes.

Female Infertility: Hormonal Biomarkers and Cycle Signals

Creator: Superpower
Published: 2025-11-06

Understand what your hormone testing results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

Female infertility and the hormonal signals that decide conception

Female infertility biomarkers are blood signals that reveal how the reproductive system is functioning. They turn the cycle’s hidden rhythms into a readable map of egg supply, ovulation, and hormone coordination. Ovarian reserve is reflected by a follicle‑derived hormone that mirrors the remaining egg pool (anti‑Müllerian hormone, AMH). Brain‑to‑ovary messengers drive follicle growth and the ovulatory surge (follicle‑stimulating hormone, FSH; luteinizing hormone, LH). Ovarian hormones show follicle maturation and luteal activity (estradiol, E2; progesterone). Thyroid and lactation hormones influence ovulation and cycle regularity (thyroid‑stimulating hormone, TSH; prolactin). Androgen and metabolic markers point to hormone excess or insulin effects that can disrupt ovulation (testosterone, DHEA‑sulfate, sex hormone–binding globulin, insulin). Reviewed together, these tests create a functional picture of the hypothalamic–pituitary–ovarian axis and its modifiers, clarifying where signals may be mistimed or opposed. The result is practical: biomarker testing makes the physiology visible, so care can target the right step—diagnosis, cycle timing, and treatment planning.

Reading a fertility panel

Female infertility blood tests map how the brain, pituitary, thyroid, and ovaries coordinate ovulation and uterine readiness. They reveal whether the system is under‑signaling, over‑signaling, or well‑timed—key for egg development, release, fertilization, and implantation. In a typical early cycle, FSH and LH sit in the low–middle range, estradiol is modest and then rises before ovulation, and progesterone is low until after ovulation when it climbs in the mid‑luteal phase. Prolactin usually stays low–normal; TSH tends to be most fertility‑friendly in the lower to mid‑normal band. Higher‑than‑expected FSH points to diminished ovarian reserve, while a relatively high LH (especially with normal FSH) can reflect ovarian androgen excess. Elevated prolactin suppresses GnRH and can halt ovulation. A high TSH signals hypothyroidism, which can lengthen cycles and impair implantation; very low TSH suggests hyperthyroidism, which also disrupts cycles. When these values are low, physiology often points to under‑drive from the hypothalamus or pituitary. Low FSH and LH mean follicles don’t mature, estradiol stays low, periods become light or absent, and ovulation may not occur; teens may have delayed puberty, and adults can notice low libido and bone loss risk over time. Low mid‑luteal progesterone reflects weak or absent ovulation, shortening the luteal phase and making implantation less likely. Low prolactin is uncommon but can indicate pituitary injury with poor milk production. Suppressed TSH from hyperthyroidism brings palpitations, weight loss, anxiety, and irregular bleeding. Big picture, these hormones are the timing signals of reproduction and also influence brain mood circuits, bone, metabolism, and cardiovascular risk. Aligning them clarifies causes of infertility, distinguishes ovarian from central or thyroid drivers, and informs prognosis for cycle regularity, egg quality, and long‑term health.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a fertility panel can and can't resolve

Female infertility blood testing provides a window into the hormonal systems that govern not only reproduction, but also energy balance, metabolism, and overall endocrine health. At Superpower, we measure six key biomarkers—FSH, LH, estradiol, progesterone, prolactin, and TSH—to map the hormonal signals that orchestrate the menstrual cycle and fertility. These hormones interact in a finely tuned network, influencing ovarian function, egg maturation, and the ability to conceive. FSH (follicle-stimulating hormone) and LH (luteinizing hormone) are pituitary hormones that regulate the growth and release of eggs from the ovaries. Estradiol, a form of estrogen, is produced by the ovaries and signals the readiness of the reproductive system. Progesterone, also from the ovaries, prepares the uterine lining for implantation. Prolactin, another pituitary hormone, primarily controls milk production but can also affect ovulation. TSH (thyroid-stimulating hormone) reflects thyroid function, which is closely linked to menstrual regularity and fertility. Balanced levels of these hormones support stable menstrual cycles, healthy ovulation, and optimal conditions for conception. Disruptions—such as elevated FSH or prolactin, low estradiol or progesterone, or abnormal TSH—can signal underlying issues with ovarian reserve, ovulation, or thyroid health, all of which can contribute to infertility. Interpretation of these biomarkers depends on factors like age, menstrual phase, pregnancy status, recent illness, medications, and laboratory methods. These variables can influence hormone levels and should be considered when evaluating results.

Frequently Asked Questions

It’s a focused hormone panel that checks how your brain, ovaries, and thyroid are coordinating reproduction. Superpower tests your blood for FSH and LH (pituitary signals), estradiol and progesterone (ovarian hormones), prolactin (pituitary hormone that can suppress ovulation), and TSH (thyroid control). Together, these show if you’re ovulating, your ovarian reserve pattern, and whether thyroid or prolactin issues are disrupting cycles.

Cycle day, pregnancy, breastfeeding, and hormonal contraception or fertility meds change results. Time of day and stress raise prolactin. Acute illness, poor sleep, shift work, intense exercise, and recent sex or nipple stimulation can shift prolactin and LH/FSH signals. Certain drugs (antipsychotics, SSRIs, opioids, thyroid meds) and supplements like high‑dose biotin can distort measurements or assays.

No fasting is usually needed. For accuracy, draw FSH/LH/estradiol on cycle days 2–3 and progesterone about 7 days after ovulation. Check prolactin in the morning, after resting, avoiding breast stimulation, sex, or strenuous exercise beforehand. Pause high‑dose biotin for 24–48 hours to prevent assay interference. If you use hormonal contraception, results reflect the medication’s effects, not baseline physiology.

Yes. Energy availability and body fat influence ovarian estrogen and ovulation (hypothalamic–pituitary–ovarian axis). High stress, poor sleep, and shift work alter GnRH/LH pulsatility and can raise prolactin. Very intense exercise and low caloric intake suppress ovulation. Alcohol and smoking can shift estradiol and progesterone. These forces change signals; they don’t diagnose a condition by themselves.

Context is key: use cycle day and lab ranges. On days 2–3, high FSH or low estradiol can suggest reduced ovarian reserve; a higher LH than FSH may fit a PCOS pattern. Mid‑luteal progesterone above roughly 3–5 ng/mL supports that ovulation occurred. Elevated prolactin can suppress GnRH and stop ovulation. Abnormal TSH points to thyroid dysfunction affecting cycles. Patterns across hormones are more informative than any single number.